Targeted therapy of advanced renal cell carcinoma
- Authors: Popov A.M.1
-
Affiliations:
- Central Clinical Hospital, Administration of the President of the Russia
- Issue: Vol 13, No 2 (2017)
- Pages: 56-62
- Section: DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER
- Published: 30.06.2017
- URL: https://oncourology.abvpress.ru/oncur/article/view/688
- DOI: https://doi.org/10.17650/1726-9776-2017-13-2-56-62
- ID: 688
Cite item
Full Text
Abstract
The standard method of treatment of patients with metastatic renal cell carcinoma is targeted therapy. Selection of drugs for these patients has remained a complex task. In the absence of predictors of effectiveness, clinical trials should serve as a reference point.
Keywords
About the authors
A. M. Popov
Central Clinical Hospital, Administration of the President of the Russia
Author for correspondence.
Email: palexdoc@yandex.ru
15 Marshala Timoshenko St., Moscow 121359 Russian Federation
References
Supplementary files

